OneMedNet Expands Commercial Reach Through Multi-Year Resale Agreement with Atropos Health

MINNEAPOLIS, Sept. 22, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us,” or “our”), a leading provider of regulatory decision-grade, AI-driven Real-World Data (RWD), today announced a strategic partnership with Atropos Health, the creator of real-world evidence for clinical decision-making under a multi-year agreement. The partnership adds OneMedNet's regulatory decision-grade data to Atropos’ platform and customer offerings under a fee arrangement adding to our Annual Recurring Revenue (ARR).

The partnership embeds OneMedNet's data directly into Atropos Health's evidence-generation platform, giving Atropos customers access to more multi-modal data drawn from our network of over 90 million patient journeys. Our multi-modal RWD brings clinical depth that elevates evidence quality well beyond what claims or Electronic Health Record (EHR) datasets alone can deliver, positioning our RWD as differentiated, high-value data within the partnership.